Patents by Inventor Thao Thi NGUYEN

Thao Thi NGUYEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing catalyst containing platinum dispersed on graphene quantum dot containing carrier for direct alcohol fuel cell and catalyst obtained by this method
    Patent number: 11870081
    Abstract: The invention relates to the method of preparing catalyst based on platinum (Pt), with a low Pt content, dispersed on carrier containing graphene quantum dots (Pt/GQDs or Pt/GO-GQDs) used for fuel cell with excellent activity in the electrochemical oxidation reaction of alcohol (for example, methanol, ethanol), applied as an anode catalyst for direct alcohol fuel cell (DAFC). At the same time, the invention also refers to the catalyst obtained by this method as an anode catalyst for DAFC.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: January 9, 2024
    Inventors: Thu Ha Thi Vu, Minh Quang Nguyen, Tho Thi Lam, Thao Thi Nguyen, Ngoc Bich Nguyen
  • Materials and methods for treatment of alpha-1 antitrypsin deficiency
    Patent number: 11851653
    Abstract: The present application provides materials and methods for treating a patient with Alpha-1 antitrypsin deficiency (AATD) both ex vivo and in vivo. In addition, the present application provides materials and methods for editing the SERPINA1 gene in a cell by genome editing.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: December 26, 2023
    Assignee: CRISPR THERAPEUTICS AG
    Inventors: Chad Albert Cowan, Roman Lvovitch Bogorad, Jeffrey Li, Ante Sven Lundberg, Matthias Johannes John, Jeffrey William Stebbins, Thao Thi Nguyen
  • METHOD OF PREPARING CATALYST CONTAINING PLATINUM DISPERSED ON GRAPHENE QUANTUM DOT CONTAINING CARRIER FOR DIRECT ALCOHOL FUEL CELL AND CATALYST OBTAINED BY THIS METHOD
    Publication number: 20210005902
    Abstract: The invention relates to the method of preparing catalyst based on platinum (Pt), with a low Pt content, dispersed on carrier containing graphene quantum dots (Pt/GQDs or Pt/GO-GQDs) used for fuel cell with excellent activity in the electrochemical oxidation reaction of alcohol (for example, methanol, ethanol), applied as an anode catalyst for direct alcohol fuel cell (DAFC). At the same time, the invention also refers to the catalyst obtained by this method as an anode catalyst for DAFC.
    Type: Application
    Filed: April 23, 2020
    Publication date: January 7, 2021
    Inventors: Thu Ha Thi Vu, Minh Quang Nguyen, Tho Thi Lam, Thao Thi Nguyen, Ngoc Bich Nguyen
  • MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY
    Publication number: 20190010490
    Abstract: The present application provides materials and methods for treating a patient with Alpha-1 antitrypsin deficiency (AATD) both ex vivo and in vivo. In addition, the present application provides materials and methods for editing the SERPINA1 gene in a cell by genome editing.
    Type: Application
    Filed: December 1, 2016
    Publication date: January 10, 2019
    Inventors: Chad Albert COWAN, Roman Lvovitch BOGORAD, Jeffrey LI, Ante Sven LUNDBERG, Matthias Johannes JOHN, Jeffrey William STEBBINS, Thao Thi NGUYEN
  • MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
    Publication number: 20180273609
    Abstract: The present application provides materials and methods for treating hemoglobinopathies. More specifically, the application provides methods for producing progenitor cells that are genetically modified via genome editing to increase the production of fetal hemoglobin (HbF), as well as modified progenitor cells (including, for example, CD34+ human hematopoietic stem cells) producing increased levels of HbF, and methods of using such cells for treating hemoglobinopathies such as sickle cell anemia and ?-thalassemia.
    Type: Application
    Filed: November 4, 2016
    Publication date: September 27, 2018
    Applicant: CRISPR Therapeutics AG
    Inventors: Matthew Hebden PORTEUS, Melanie Ruth ALLEN, Chad Albert COWAN, Ante Sven LUNDBERG, Michelle I-Ching LIN, Jeffrey LI, Thao Thi NGUYEN